Table II.
Cytokine concentrations (pg/mL) in the BAL fluid. Data represent the mean ± SD, with minimum and maximum concentrations shown in parentheses.
Adult control (n = 30) | Moderate asthma (n = 22) | Severe asthma (n = 31) | Wilks’ lambda1 | p-value2 | |
---|---|---|---|---|---|
IL-1β | 0 (0–0.01) | 0.07 ± 0.07a (0–0.23) | 0.06 ± 0.07a (0–0.36) | 0.742 | < 0.001* |
IL-2 | 0.05 ± 0.08 (0–0.37) | 0.07 ± 0.05 (0–0.21) | 0.08 ± 0.11 (0–0.62) | 0.975 | 0.386 |
IL-4 | 0.53 ± 0.73 (0–2.76) | 0.65 ± 0.84 (0–2.40) | 0.55 ± 0.74 (0–2.08) | 0.950 | 0.798 |
IL-5 | 0.06 ± 0.16 (0–0.75) | 0.29 ± 0.56 (0–2.03) | 0.39 ± 1.03 (0–4.53) | 0.947 | 0.225 |
IL-6 | 0.59 ± 0.48 (0.18–2.11) | 5.60 ± 3.73a (1.23–17.09) | 8.27 ± 11.65a (0.93–56.15) | 0.744 | 0.001* |
IL-7 | 0.76 ± 1.69 (0–8.52) | 1.24 ± 1.30 (0.03–6.55) | 0.94 ± 0.98 (0.01–4.53) | 0.983 | 0.459 |
IL-10 | 0.01 ± 0.03 (0–0.15) | 0.81 ± 1.86 (0–8.19) | 0.69 ± 1.46 (0–7.33) | 0.934 | 0.082 |
IL-12 (p70) | 0.04 ± 0.06 (0–0.19) | 0.10 ± 0.11 (0–0.39) | 0.14 ± 0.18 (0–0.81) | 0.893 | 0.030 |
IL-13 | 0.02 ± 0.12 (0–0.55) | 0.62 ± 0.52a (0–2.32) | 1.04 ± 1.40a (0–5.96) | 0.690 | < 0.001* |
IFNγ | 0.03 ± 0.13 (0–0.60) | 0.26 ± 0.38 (0–1.41) | 0.14 ± 0.21 (0–0.91) | 0.876 | 0.008 |
GM-CSF | 0.21 ± 0.21 (0–0.75) | 0.34 ± 0.29 (0–1.00) | 0.22 ± 0.25 (0–1.32) | 0.929 | 0.119 |
TNFα | 0.19 ± 0.17 (0.04–0.74) | 0.51 ± 0.91 (0.04–4.44) | 1.47 ± 5.04 (0.06–25.71) | 0.953 | 0.259 |
Smaller values indicate better discrimination between groups
To adjust for multiple comparisons, significance was defined as α ≤ 0.002
Indicates significant differences between groups after Bonferroni correction.
p < 0.01 vs. adult control